Trial NCT02438007

View at ClinicalTrials.gov 
Org. Study IDs: ARMOR3-SV

Last trial update was posted on 2023-03-15

MeSH Interventions

3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Prostate Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID